Sun Pharma Inks Agreement With US-Based Pharmazz on Cerebral Ischemic Stroke Drug September 15, 2023 The Indian multinational pharmaceutical company, Sun Pharmaceutical has entered into a licence agreement with US-based Pharmazz Inc. to commercialise Tyvalzi (Sovateltide), in India.
British-Swedish Pharma Giant AstraZeneca's Alexion Partners with USA's Verge Genomics in a $840 Mn+ Deal September 13, 2023 British-Swedish pharmaceutical major, AstraZeneca, has formed a partnership between its rare disease unit, Alexion, with American biotechnology firm Verge Genomics. The partnership deal is reported to be valued at over $840 million
Page 1 of 1